vakcinakandidátusokat

Vakcinakandidátusok refers to potential vaccines that are in various stages of development and testing. These candidates have not yet received regulatory approval and are not available for public use. The process of developing a vaccine candidate is a lengthy and rigorous one, typically involving several phases of research and clinical trials. Initial laboratory studies are conducted to assess the safety and immunogenicity of a potential vaccine. If these early studies are promising, the candidate progresses to clinical trials in humans. These trials are divided into phases, with Phase 1 testing safety and dosage in a small group of volunteers, Phase 2 evaluating efficacy and side effects in a larger group, and Phase 3 confirming effectiveness, monitoring side effects, and comparing it to existing treatments or placebos in a very large population. Only after successfully completing all phases and demonstrating safety and efficacy can a vaccine candidate become an approved vaccine. The term is frequently used during public health emergencies when numerous research groups are rapidly working on potential solutions.